{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:01:45Z","timestamp":1791939705378,"version":"4.3.4"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Mayo Clinical Graduate School of Biomedical Sciences, PhD Training Grant in Basic Immunology","award":["(NIH R25 GM055252 24"],"award-info":[{"award-number":["(NIH R25 GM055252 24"]}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01 AR056647"],"award-info":[{"award-number":["R01 AR056647"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Periprosthetic joint infection (PJI) is a major complication of total joint arthroplasty, typically necessitating surgical intervention and prolonged antimicrobial therapy. Currently, there is no perfect assay for PJI diagnosis. Proteomic profiling of sonicate fluid has the potential to differentiate PJI from non-infectious arthroplasty failure (NIAF) and possibly clinical subsets of PJI and\/or NIAF. In this study, 200 sonicate fluid samples, including 90 from subjects with NIAF (23 aseptic loosening, 35 instability, 10 stiffness, five osteolysis, and 17 other) and 110 from subjects with PJI (40 <jats:italic>Staphylococcus aureus<\/jats:italic>, 40 <jats:italic>Staphylococcus epidermidis<\/jats:italic>, 10 <jats:italic>Staphylococcus lugdunensis<\/jats:italic>, 10 <jats:italic>Streptococcus agalactiae<\/jats:italic>, and 10 <jats:italic>Enterococcus faecalis<\/jats:italic>) were analyzed by proximity extension assay  using the 92 protein Inflammation Panel from Olink Proteomics. Thirty-seven of the 92 proteins examined, including CCL20, OSM, EN-RAGE, IL8, and IL6, were differentially expressed in PJI versus NIAF sonicate fluid samples, with none of the 92 proteins differentially expressed between staphylococcal versus non-staphylococcal PJI, nor between the different types of NIAF studied. IL-17A and CCL11 were differentially expressed between PJI caused by different bacterial species, with IL-17A detected at higher levels in <jats:italic>S. aureus<\/jats:italic> compared to <jats:italic>S. epidermidis<\/jats:italic> and <jats:italic>S. lugdunensis<\/jats:italic> PJI, and CCL11 detected at higher levels in <jats:italic>S. epidermidis<\/jats:italic> compared to <jats:italic>S. aureus<\/jats:italic> and <jats:italic>S. agalactiae<\/jats:italic> PJI. Receiver operative characteristic curve analysis identified individual proteins and combinations of proteins that could differentiate PJI from NIAF. Overall, proteomic profiling using this small protein panel was able to differentiate between PJI and NIAF sonicate samples and provide a better understanding of the immune response during arthroplasty failure.<\/jats:p>","DOI":"10.1038\/s41598-022-20444-9","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T19:11:58Z","timestamp":1664305918000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["A 92 protein inflammation panel performed on sonicate fluid differentiates periprosthetic joint infection from non-infectious causes of arthroplasty failure"],"prefix":"10.1038","volume":"12","author":[{"given":"Cody R.","family":"Fisher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold I.","family":"Salmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Mandrekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerryl E.","family":"Greenwood-Quaintance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Abdel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,27]]},"reference":[{"key":"20444_CR1","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1128\/CMR.00111-13","volume":"27","author":"AJ Tande","year":"2014","unstructured":"Tande, A. J. & Patel, R. Prosthetic joint infection. Clin. Microbiol. Rev. 27, 302\u2013345 (2014).","journal-title":"Clin. Microbiol. Rev."},{"key":"20444_CR2","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.berh.2006.08.003","volume":"20","author":"W Zimmerli","year":"2006","unstructured":"Zimmerli, W. Infection and musculoskeletal conditions: Prosthetic-joint-associated infections. Best Pract. Res. Clin. Rheumatol. 20, 1045\u20131063 (2006).","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"20444_CR3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/01.qco.0000235161.85925.e8","volume":"19","author":"A Trampuz","year":"2006","unstructured":"Trampuz, A. & Widmer, A. F. Infections associated with orthopedic implants. Curr. Opin. Infect. Dis. 19, 349\u2013356 (2006).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"20444_CR4","doi-asserted-by":"publisher","first-page":"780","DOI":"10.2106\/00004623-200704000-00012","volume":"89","author":"S Kurtz","year":"2007","unstructured":"Kurtz, S., Ong, K., Lau, E., Mowat, F. & Halpern, M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J. Bone Jt. Surg. 89, 780\u2013785 (2007).","journal-title":"J. Bone Jt. Surg."},{"key":"20444_CR5","doi-asserted-by":"crossref","unstructured":"Gutowski, C. J., Chen, A. F. & Parvizi, J. The Incidence and Socioeconomic Impact of Periprosthetic Joint Infection: United States Perspective, 19\u201326, (Periprosthetic Joint Infections. Springer, 2016).","DOI":"10.1007\/978-3-319-30091-7_2"},{"key":"20444_CR6","doi-asserted-by":"publisher","first-page":"E52","DOI":"10.1503\/cjs.004219","volume":"63","author":"M Jason Akindolire","year":"2020","unstructured":"Jason Akindolire, M., Morcos, M. W., Howard, J. L., Lanting, B. A. & Vasarhelyi, E. M. The economic impact of periprosthetic infection in total hip arthroplasty. Can. J. Surg. 63, E52\u2013E56 (2020).","journal-title":"Can. J. Surg."},{"key":"20444_CR7","doi-asserted-by":"publisher","first-page":"732.e1","DOI":"10.1016\/j.cmi.2016.05.004","volume":"22","author":"N Benito","year":"2016","unstructured":"Benito, N. et al. Time trends in the aetiology of prosthetic joint infections: A multicentre cohort study. Clin. Microbiol. Infect. 22, 732.e1-732.e8 (2016).","journal-title":"Clin. Microbiol. Infect."},{"key":"20444_CR8","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1086\/605593","volume":"49","author":"P-H Hsieh","year":"2009","unstructured":"Hsieh, P.-H. et al. Gram-negative prosthetic joint infections: Risk factors and outcome of treatment. Clin. Infect. Dis. 49, 1036\u20131043 (2009).","journal-title":"Clin. Infect. Dis."},{"key":"20444_CR9","doi-asserted-by":"publisher","first-page":"e00026","DOI":"10.1128\/MMBR.00026-19","volume":"84","author":"K Schilcher","year":"2020","unstructured":"Schilcher, K. & Horswill, A. R. Staphylococcal biofilm development: Structure, regulation, and treatment strategies. Microbiol. Mol. Biol. Rev. 84, e00026-e119 (2020).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"20444_CR10","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41579-018-0019-y","volume":"16","author":"CR Arciola","year":"2018","unstructured":"Arciola, C. R., Campoccia, D. & Montanaro, L. Implant infections: Adhesion, biofilm formation and immune evasion. Nat. Rev. Microbiol. 16, 397\u2013409 (2018).","journal-title":"Nat. Rev. Microbiol."},{"key":"20444_CR11","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/cis803","volume":"56","author":"DR Osmon","year":"2013","unstructured":"Osmon, D. R. et al. Diagnosis and management of prosthetic joint infection: Clinical practice guidelines by the infectious diseases society of America. Clin. Infect. Dis. 56, e1\u2013e25 (2013).","journal-title":"Clin. Infect. Dis."},{"key":"20444_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.5435\/JAAOS-22-03-153","volume":"22","author":"PRT Kuzyk","year":"2014","unstructured":"Kuzyk, P. R. T. et al. Two-stage revision arthroplasty for management of chronic periprosthetic hip and knee infection: Techniques, controversies, and outcomes. J. Am. Acad. Orthop. Surg. 22, 153\u2013164 (2014).","journal-title":"J. Am. Acad. Orthop. Surg."},{"key":"20444_CR13","doi-asserted-by":"publisher","first-page":"138","DOI":"10.5371\/hp.2018.30.3.138","volume":"30","author":"C Li","year":"2018","unstructured":"Li, C., Renz, N. & Trampuz, A. Management of periprosthetic joint infection. Hip Pelvis 30, 138\u2013146 (2018).","journal-title":"Hip Pelvis"},{"key":"20444_CR14","first-page":"694","volume":"86","author":"M Bonnin","year":"2000","unstructured":"Bonnin, M., Deschamps, G., Neyret, P. & Chambat, P. Revision in non-infected total knee arthroplasty: An analysis of 69 consecutive cases. Rev. Chir. Orthop. Repar. Appar. Mot. 86, 694\u2013706 (2000).","journal-title":"Rev. Chir. Orthop. Repar. Appar. Mot."},{"key":"20444_CR15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.5435\/JAAOS-D-19-00860","volume":"29","author":"G Kelmer","year":"2021","unstructured":"Kelmer, G., Stone, A. H., Turcotte, J. & King, P. J. Reasons for revision: Primary total hip arthroplasty mechanisms of failure. J. Am. Acad. Orthop. Surg. 29, 78\u201387 (2021).","journal-title":"J. Am. Acad. Orthop. Surg."},{"key":"20444_CR16","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jor.2020.12.008","volume":"23","author":"DT Mathis","year":"2021","unstructured":"Mathis, D. T., Lohrer, L., Amsler, F. & Hirschmann, M. T. Reasons for failure in primary total knee arthroplasty: An analysis of prospectively collected registry data. J. Orthop. 23, 60\u201366 (2021).","journal-title":"J. Orthop."},{"key":"20444_CR17","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1302\/2046-3758.55.BJR-2016-0086","volume":"5","author":"NA Athanasou","year":"2016","unstructured":"Athanasou, N. A. The pathobiology and pathology of aseptic implant failure. Bone Jt. Res. 5, 162\u2013168 (2016).","journal-title":"Bone Jt. Res."},{"key":"20444_CR18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/01.blo.0000087324.60612.93","volume":"414","author":"A Trampuz","year":"2003","unstructured":"Trampuz, A., Osmon, D. R., Hanssen, A. D., Steckelberg, J. M. & Patel, R. Molecular and antibiofilm approaches to prosthetic joint infection. Clin. Orthop. Relat. Res. 414, 69\u201388 (2003).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"20444_CR19","first-page":"138","volume":"88","author":"J Parvizi","year":"2006","unstructured":"Parvizi, J., Ghanem, E., Menashe, S., Barrack, R. L. & Bauer, T. W. Periprosthetic infection: What are the diagnostic challenges?. J. Bone Jt. Surg. 88, 138\u2013147 (2006).","journal-title":"J. Bone Jt. Surg."},{"key":"20444_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2106\/JBJS.20.00749","volume":"103","author":"C Deirmengian","year":"2021","unstructured":"Deirmengian, C. et al. Validation of the alpha defensin lateral flow test for periprosthetic joint infection. J. Bone Jt. Surg. 103, 115\u2013122 (2021).","journal-title":"J. Bone Jt. Surg."},{"key":"20444_CR21","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1007\/s00264-016-3306-0","volume":"40","author":"J Pupaibool","year":"2016","unstructured":"Pupaibool, J., Fulnecky, E. J., Swords, R. L., Sistrunk, W. W. & Haddow, A. D. Alpha-defensin: Novel synovial fluid biomarker for the diagnosis of periprosthetic joint infection. Int. Orthop. 40, 2447\u20132452 (2016).","journal-title":"Int. Orthop."},{"key":"20444_CR22","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.2106\/JBJS.OA.20.00067","volume":"6","author":"H Keemu","year":"2021","unstructured":"Keemu, H. et al. Novel biomarkers for diagnosing periprosthetic joint infection from synovial fluid and serum. JBJS Open Access 6, e20 (2021).","journal-title":"JBJS Open Access"},{"key":"20444_CR23","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.1128\/JCM.00834-12","volume":"50","author":"E Gomez","year":"2012","unstructured":"Gomez, E. et al. Prosthetic joint infection diagnosis using broad-range PCR of biofilms dislodged from knee and hip arthroplasty surfaces using sonication. J. Clin. Microbiol. 50, 3501\u20133508 (2012).","journal-title":"J. Clin. Microbiol."},{"key":"20444_CR24","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1093\/cid\/ciy303","volume":"67","author":"MJ Thoendel","year":"2018","unstructured":"Thoendel, M. J. et al. Identification of prosthetic joint infection pathogens using a shotgun metagenomics approach. Clin. Infect. Dis. 67, 1333\u20131338 (2018).","journal-title":"Clin. Infect. Dis."},{"key":"20444_CR25","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s00264-022-05357-6","volume":"46","author":"AT Hantouly","year":"2022","unstructured":"Hantouly, A. T. et al. Synovial fluid calprotectin in diagnosing periprosthetic joint infection: A meta-analysis. Int. Ortho. 46, 971\u2013981 (2022).","journal-title":"Int. Ortho."},{"key":"20444_CR26","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.arth.2017.11.006","volume":"33","author":"M Wouthuyzen-Bakker","year":"2018","unstructured":"Wouthuyzen-Bakker, M. et al. Synovial calprotectin: An inexpensive biomarker to exclude a chronic prosthetic joint infection. J. Arthroplast. 33, 1149\u20131153 (2018).","journal-title":"J. Arthroplast."},{"key":"20444_CR27","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1002\/jor.24766","volume":"38","author":"K Sharma","year":"2020","unstructured":"Sharma, K. et al. Comparative analysis of 23 synovial fluid biomarkers for hip and knee periprosthetic joint infection detection. J. Orthop. Res. 38, 2664\u20132674 (2020).","journal-title":"J. Orthop. Res."},{"key":"20444_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.arth.2018.09.047","volume":"34","author":"A Vergara","year":"2019","unstructured":"Vergara, A. et al. Evaluation of lipocalin-2 as a biomarker of periprosthetic joint infection. J. Arthroplast. 34, 123\u2013125 (2019).","journal-title":"J. Arthroplast."},{"key":"20444_CR29","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.2106\/JBJS.18.01483","volume":"101","author":"C Wang","year":"2019","unstructured":"Wang, C. et al. LTF, PRTN3, and MNDA in synovial fluid as promising biomarkers for periprosthetic joint infection: Identification by quadrupole orbital-trap mass spectrometry. J. Bone Jt. Surg. 101, 2226\u20132234 (2019).","journal-title":"J. Bone Jt. Surg."},{"key":"20444_CR30","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1302\/2058-5241.1.160019","volume":"1","author":"A Shahi","year":"2017","unstructured":"Shahi, A. & Parvizi, J. The role of biomarkers in the diagnosis of periprosthetic joint infection. EFORT Open Rev. 1, 275\u2013278 (2017).","journal-title":"EFORT Open Rev."},{"key":"20444_CR31","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1056\/NEJMoa061588","volume":"357","author":"A Trampuz","year":"2007","unstructured":"Trampuz, A. et al. Sonication of removed hip and knee prostheses for diagnosis of infection. N. Engl. J. Med. 357, 654\u2013663 (2007).","journal-title":"N. Engl. J. Med."},{"key":"20444_CR32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1302\/2058-5241.6.200118","volume":"6","author":"J Esteban","year":"2021","unstructured":"Esteban, J. & G\u00f3mez-Barrena, E. An update about molecular biology techniques to detect orthopaedic implant-related infections. EFORT Open Rev. 6, 93\u2013100 (2021).","journal-title":"EFORT Open Rev."},{"key":"20444_CR33","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12891-021-04116-9","volume":"22","author":"H Yin","year":"2021","unstructured":"Yin, H., Xu, D. & Wang, D. Diagnostic value of next-generation sequencing to detect periprosthetic joint infection. BMC Musculoskelet. Disord. 22, 252\u2013252 (2021).","journal-title":"BMC Musculoskelet. Disord."},{"key":"20444_CR34","doi-asserted-by":"publisher","first-page":"S619","DOI":"10.1093\/ofid\/ofaa439.1378","volume":"7","author":"T Masters","year":"2020","unstructured":"Masters, T. et al. 1193. Human transcriptomic analysis of periprosthetic joint infection. Open Forum Infect. Dis. 7, S619\u2013S619 (2020).","journal-title":"Open Forum Infect. Dis."},{"key":"20444_CR35","doi-asserted-by":"publisher","first-page":"e95192","DOI":"10.1371\/journal.pone.0095192","volume":"9","author":"E Assarsson","year":"2014","unstructured":"Assarsson, E. et al. Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS One 9, e95192\u2013e95192 (2014).","journal-title":"PLoS One"},{"key":"20444_CR36","doi-asserted-by":"publisher","first-page":"16198","DOI":"10.1038\/s41598-020-72671-7","volume":"10","author":"N Masoudzadeh","year":"2020","unstructured":"Masoudzadeh, N. et al. Molecular signatures of anthroponotic cutaneous leishmaniasis in the lesions of patients infected with Leishmania tropica. Sci. Rep. 10, 16198 (2020).","journal-title":"Sci. Rep."},{"key":"20444_CR37","doi-asserted-by":"publisher","first-page":"102019","DOI":"10.1016\/j.tube.2020.102019","volume":"126","author":"VACM Koeken","year":"2021","unstructured":"Koeken, V. A. C. M. et al. Cerebrospinal fluid IL-1\u03b2 is elevated in tuberculous meningitis patients but not associated with mortality. Tuberculosis 126, 102019 (2021).","journal-title":"Tuberculosis"},{"key":"20444_CR38","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1038\/s41598-019-38691-8","volume":"9","author":"K Klarstr\u00f6m Engstr\u00f6m","year":"2019","unstructured":"Klarstr\u00f6m Engstr\u00f6m, K., Zhang, B. & Demirel, I. Human renal fibroblasts are strong immunomobilizers during a urinary tract infection mediated by uropathogenic Escherichia coli. Sci. Rep. 9, 2296 (2019).","journal-title":"Sci. Rep."},{"key":"20444_CR39","doi-asserted-by":"publisher","first-page":"6357","DOI":"10.1038\/s41598-021-85877-0","volume":"11","author":"H Patel","year":"2021","unstructured":"Patel, H. et al. Proteomic blood profiling in mild, severe and critical COVID-19 patients. Sci. Rep. 11, 6357 (2021).","journal-title":"Sci. Rep."},{"key":"20444_CR40","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1126\/science.abc6261","volume":"369","author":"S Arunachalam Prabhu","year":"2020","unstructured":"Arunachalam Prabhu, S. et al. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science 369, 1210\u20131220 (2020).","journal-title":"Science"},{"key":"20444_CR41","doi-asserted-by":"publisher","first-page":"e0197235","DOI":"10.1371\/journal.pone.0197235","volume":"13","author":"J Panezai","year":"2018","unstructured":"Panezai, J., Ghaffar, A., Altamash, M., Engstr\u00f6m, P.-E. & Larsson, A. Periodontal disease influences osteoclastogenic bone markers in subjects with and without rheumatoid arthritis. PLoS One 13, e0197235 (2018).","journal-title":"PLoS One"},{"key":"20444_CR42","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41467-019-14003-6","volume":"11","author":"MM Weivoda","year":"2020","unstructured":"Weivoda, M. M. et al. Identification of osteoclast-osteoblast coupling factors in humans reveals links between bone and energy metabolism. Nat. Commun. 11, 87 (2020).","journal-title":"Nat. Commun."},{"key":"20444_CR43","doi-asserted-by":"publisher","first-page":"100292","DOI":"10.1016\/j.bonr.2020.100292","volume":"13","author":"M Bue","year":"2020","unstructured":"Bue, M. et al. Inflammatory proteins in infected bone tissue: An explorative porcine study. Bone Rep. 13, 100292 (2020).","journal-title":"Bone Rep."},{"key":"20444_CR44","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.arth.2018.02.078","volume":"33","author":"J Parvizi","year":"2018","unstructured":"Parvizi, J. et al. The 2018 definition of periprosthetic hip and knee infection: An evidence-based and validated criteria. J. Arthroplast. 33, 1309-1314.e2 (2018).","journal-title":"J. Arthroplast."},{"key":"20444_CR45","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.arth.2004.02.015","volume":"19","author":"JJ Callaghan","year":"2004","unstructured":"Callaghan, J. J., O\u2019Rourke, M. R. & Saleh, K. J. Why knees fail: Lessons learned. J. Arthroplast. 19, 31\u201334 (2004).","journal-title":"J. Arthroplast."},{"key":"20444_CR46","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ocl.2015.09.007","volume":"47","author":"U Cottino","year":"2016","unstructured":"Cottino, U., Sculco, P. K., Sierra, R. J. & Abdel, M. P. Instability after total knee arthroplasty. Orthop. Clin. North Am. 47, 311\u2013316 (2016).","journal-title":"Orthop. Clin. North Am."},{"key":"20444_CR47","doi-asserted-by":"publisher","first-page":"436","DOI":"10.5435\/00124635-200411000-00008","volume":"12","author":"MH Gonzalez","year":"2004","unstructured":"Gonzalez, M. H. & Mekhail, A. O. The failed total knee arthroplasty: Evaluation and etiology. J. Am. Acad. Orthop. Surg. 12, 436\u2013446 (2004).","journal-title":"J. Am. Acad. Orthop. Surg."},{"key":"20444_CR48","doi-asserted-by":"publisher","first-page":"S272","DOI":"10.1016\/j.arth.2021.02.008","volume":"36","author":"EB Gausden","year":"2021","unstructured":"Gausden, E. B. et al. Total hip arthroplasty for femoral neck fracture: What are the contemporary reasons for failure?. J. Arthroplast. 36, S272\u2013S276 (2021).","journal-title":"J. Arthroplast."},{"key":"20444_CR49","doi-asserted-by":"publisher","first-page":"933","DOI":"10.5435\/JAAOS-D-17-00842","volume":"27","author":"CK Ledford","year":"2019","unstructured":"Ledford, C. K., Perry, K. I., Hanssen, A. D. & Abdel, M. P. What are the contemporary etiologies for revision surgery and revision after primary, noncemented total hip arthroplasty?. J. Am. Acad. Orthop. Surg. 27, 933\u2013938 (2019).","journal-title":"J. Am. Acad. Orthop. Surg."},{"key":"20444_CR50","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1016\/j.arth.2021.03.051","volume":"36","author":"AR Owen","year":"2021","unstructured":"Owen, A. R. et al. Acquired idiopathic stiffness after contemporary total knee arthroplasty: Incidence, risk factors, and results over 25 years. J. Arthroplast. 36, 2980\u20132985 (2021).","journal-title":"J. Arthroplast."},{"key":"20444_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2022.06.013","author":"HI Salmons","year":"2022","unstructured":"Salmons, H. I. et al. Revision total hip arthroplasty for aseptically failed metal-on-metal hip resurfacing arthroplasty. J. Arthroplast. https:\/\/doi.org\/10.1016\/j.arth.2022.06.013 (2022).","journal-title":"J. Arthroplast."},{"key":"20444_CR52","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248\u2013254 (1976).","journal-title":"Anal. Biochem."},{"key":"20444_CR53","unstructured":"Team\" RC. R: A language and environment for statistical computing, R Foundation for Statistical Computing, (2020) https:\/\/www.R-project.org\/."},{"key":"20444_CR54","unstructured":"Kassambara, A. & Mundt, F. factoextra: Extract and Visualize the Results of Multivariate Data Analyses, vR package version 1.0.7. (2020). https:\/\/CRAN.R-project.org\/package=factoextra."},{"key":"20444_CR55","doi-asserted-by":"crossref","unstructured":"Gu, Z. E. R. & Schlesner, M. Complex Heatmaps Reveal Patterns and Correlations in Multidimensional Genomic Data, (2016) https:\/\/www.bioconductor.org\/packages\/release\/bioc\/html\/ComplexHeatmap.html.","DOI":"10.1093\/bioinformatics\/btw313"},{"key":"20444_CR56","unstructured":"Konopka, T. umap: Uniform Manifold Approximation and Projection, vR package version 0.2.7.0. (2020) https:\/\/CRAN.R-project.org\/package=umap."},{"issue":"2","key":"20444_CR57","first-page":"1","volume":"79","author":"MC Sachs","year":"2017","unstructured":"Sachs, M. C. plotROC: A tool for plotting ROC curves. J. Stat. Softw. Code Snippets 79(2), 1\u201319 (2017).","journal-title":"J. Stat. Softw. Code Snippets"},{"key":"20444_CR58","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: Elegant Graphics for Data Analysis","author":"H Wickham","year":"2016","unstructured":"Wickham, H. ggplot2: Elegant Graphics for Data Analysis (Springer-Verlag, 2016)."},{"key":"20444_CR59","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/COH.0b013e32833ed742","volume":"5","author":"B Grund","year":"2010","unstructured":"Grund, B. & Sabin, C. Analysis of biomarker data: Logs, odds ratios, and receiver operating characteristic curves. Curr. Opin. HIV AIDS 5, 473\u2013479 (2010).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"20444_CR60","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1097\/JTO.0b013e3181ec173d","volume":"5","author":"JN Mandrekar","year":"2010","unstructured":"Mandrekar, J. N. Receiver operating characteristic curve in diagnostic test assessment. J. Thorac. Oncol. 5, 1315\u20131316 (2010).","journal-title":"J. Thorac. Oncol."},{"key":"20444_CR61","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1165\/rcmb.2002-0272OC","volume":"29","author":"TD Starner","year":"2003","unstructured":"Starner, T. D., Barker, C. K., Jia, H. P., Kang, Y. & McCray, P. B. CCL20 is an inducible product of human airway epithelia with innate immune properties. Am. J. Respir. Cell Mol. Biol. 29, 627\u2013633 (2003).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"20444_CR62","doi-asserted-by":"crossref","unstructured":"Ranasinghe, R. & Eri, R. CCR6\u2013CCL20 axis in IBD: What have we learnt in the last 20 years? Gastrointest Disord 1 (2019).","DOI":"10.20944\/preprints201808.0381.v1"},{"key":"20444_CR63","doi-asserted-by":"publisher","first-page":"6621","DOI":"10.4049\/jimmunol.164.12.6621","volume":"164","author":"B Homey","year":"2000","unstructured":"Homey, B. et al. Up-regulation of macrophage inflammatory protein-3\u03b1\/CCL20 and CC chemokine receptor 6 in psoriasis. J. Immunol. 164, 6621 (2000).","journal-title":"J. Immunol."},{"key":"20444_CR64","doi-asserted-by":"publisher","first-page":"5186","DOI":"10.3390\/ijms21155186","volume":"21","author":"S Kadomoto","year":"2020","unstructured":"Kadomoto, S., Izumi, K. & Mizokami, A. The CCL20-CCR6 axis in cancer progression. Int. J. Mol. 21, 5186 (2020).","journal-title":"Int. J. Mol."},{"key":"20444_CR65","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12974-016-0630-7","volume":"13","author":"J Hu","year":"2016","unstructured":"Hu, J., Yang, Z., Li, X. & Lu, H. C-C motif chemokine ligand 20 regulates neuroinflammation following spinal cord injury via Th17 cell recruitment. J. Neuroinflammation 13, 162 (2016).","journal-title":"J. Neuroinflammation"},{"key":"20444_CR66","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S1359-6101(03)00049-2","volume":"14","author":"E Schutyser","year":"2003","unstructured":"Schutyser, E., Struyf, S. & Van Damme, J. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev. 14, 409\u2013426 (2003).","journal-title":"Cytokine Growth Factor Rev."},{"key":"20444_CR67","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1189\/jlb.0103024","volume":"74","author":"D Yang","year":"2003","unstructured":"Yang, D. et al. Many chemokines including CCL20\/MIP-3\u03b1 display antimicrobial activity. J. Leukoc. Biol. 74, 448\u2013455 (2003).","journal-title":"J. Leukoc. Biol."},{"key":"20444_CR68","doi-asserted-by":"publisher","first-page":"37647","DOI":"10.1074\/jbc.M203907200","volume":"277","author":"DM Hoover","year":"2002","unstructured":"Hoover, D. M. et al. The structure of human macrophage inflammatory protein-3\u03b1\/CCL20: Linking antimicrobial and CC chemokine receptor-6-binding activities with human \u03b2-defensins. J. Biol. Chem. 277, 37647\u201337654 (2002).","journal-title":"J. Biol. Chem."},{"key":"20444_CR69","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1093\/infdis\/jiv206","volume":"212","author":"W Guesdon","year":"2015","unstructured":"Guesdon, W. et al. CCL20 displays antimicrobial activity against Cryptosporidium parvum, but its expression is reduced during infection in the intestine of neonatal mice. J. Infect. 212, 1332\u20131340 (2015).","journal-title":"J. Infect."},{"key":"20444_CR70","doi-asserted-by":"publisher","first-page":"512103","DOI":"10.1155\/2013\/512103","volume":"2013","author":"CD Richards","year":"2013","unstructured":"Richards, C. D., Gong, R. & Horwood, N. The enigmatic cytokine oncostatin M and roles in disease. ISRN Inflamm. 2013, 512103 (2013).","journal-title":"ISRN Inflamm."},{"key":"20444_CR71","doi-asserted-by":"publisher","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","volume":"6","author":"T Tanaka","year":"2014","unstructured":"Tanaka, T., Narazaki, M. & Kishimoto, T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb. Perspect. Biol. 6, a016295\u2013a016295 (2014).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"20444_CR72","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrrheum.2017.83","volume":"13","author":"S Rose-John","year":"2017","unstructured":"Rose-John, S., Winthrop, K. & Calabrese, L. The role of IL-6 in host defence against infections: Immunobiology and clinical implications. Nat. Rev. Rheumatol. 13, 399\u2013409 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"20444_CR73","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1093\/infdis\/jiaa009","volume":"221","author":"Y Gong","year":"2020","unstructured":"Gong, Y. et al. Oncostatin M is a prognostic biomarker and inflammatory mediator for sepsis. J. Infect. Dis. 221, 1989\u20131998 (2020).","journal-title":"J. Infect. Dis."},{"key":"20444_CR74","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/bonekey.2014.22","volume":"3","author":"NA Sims","year":"2014","unstructured":"Sims, N. A. & Quinn, J. M. W. Osteoimmunology: Oncostatin M as a pleiotropic regulator of bone formation and resorption in health and disease. BoneKEy Rep. 3, 527\u2013527 (2014).","journal-title":"BoneKEy Rep."},{"key":"20444_CR75","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1136\/gut.52.6.847","volume":"52","author":"D Foell","year":"2003","unstructured":"Foell, D. et al. Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut 52, 847 (2003).","journal-title":"Gut"},{"key":"20444_CR76","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1093\/rheumatology\/keg385","volume":"42","author":"D Foell","year":"2003","unstructured":"Foell, D. et al. Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. Rheumatology 42, 1383\u20131389 (2003).","journal-title":"Rheumatology"},{"key":"20444_CR77","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1189\/jlb.3RU0316-144R","volume":"100","author":"I Ushach","year":"2016","unstructured":"Ushach, I. & Zlotnik, A. Biological role of granulocyte macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) on cells of the myeloid lineage. J. Leukoc. Biol. 100, 481\u2013489 (2016).","journal-title":"J. Leukoc. Biol."},{"key":"20444_CR78","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V","volume":"46","author":"ER Stanley","year":"1997","unstructured":"Stanley, E. R. et al. Biology and action of colony-stimulating factor-1. Mol. Reprod. Dev. 46, 4\u201310 (1997).","journal-title":"Mol. Reprod. Dev."},{"key":"20444_CR79","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nri1996","volume":"7","author":"K Shortman","year":"2007","unstructured":"Shortman, K. & Naik, S. H. Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 7, 19\u201330 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"20444_CR80","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nm.3197","volume":"19","author":"P Guermonprez","year":"2013","unstructured":"Guermonprez, P. et al. Inflammatory Flt3l is essential to mobilize dendritic cells and for T cell responses during Plasmodium infection. Nat. Med. 19, 730\u2013738 (2013).","journal-title":"Nat. Med."},{"key":"20444_CR81","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s12276-020-0484-z","volume":"52","author":"SH Mun","year":"2020","unstructured":"Mun, S. H., Park, P. S. U. & Park-Min, K.-H. The M-CSF receptor in osteoclasts and beyond. Exp. Mol. Med. 52, 1239\u20131254 (2020).","journal-title":"Exp. Mol. Med."},{"key":"20444_CR82","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","volume":"473","author":"BF Boyce","year":"2008","unstructured":"Boyce, B. F. & Xing, L. Functions of RANKL\/RANK\/OPG in bone modeling and remodeling. Arch. Biochem. Biophys. 473, 139\u2013146 (2008).","journal-title":"Arch. Biochem. Biophys."},{"key":"20444_CR83","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41413-020-0104-5","volume":"8","author":"B Shu","year":"2020","unstructured":"Shu, B. et al. Inhibition of Axin1 in osteoblast precursor cells leads to defects in postnatal bone growth through suppressing osteoclast formation. Bone Res. 8, 31 (2020).","journal-title":"Bone Res."},{"key":"20444_CR84","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1089\/jir.2008.0027","volume":"29","author":"SL Deshmane","year":"2009","unstructured":"Deshmane, S. L., Kremlev, S., Amini, S. & Sawaya, B. E. Monocyte chemoattractant protein-1 (MCP-1): An overview. J. Interferon Cytokine Res. 29, 313\u2013326 (2009).","journal-title":"J. Interferon Cytokine Res."},{"key":"20444_CR85","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1755-7682-3-11","volume":"3","author":"A Shahzad","year":"2010","unstructured":"Shahzad, A., Knapp, M., Lang, I. & K\u00f6hler, G. Interleukin 8 (IL-8): A universal biomarker?. Int. Arch. Med. 3, 11\u201311 (2010).","journal-title":"Int. Arch. Med."},{"key":"20444_CR86","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S1359-6101(02)00045-X","volume":"13","author":"P Menten","year":"2002","unstructured":"Menten, P., Wuyts, A. & Van Damme, J. Macrophage inflammatory protein-1. Cytokine Growth Factor Rev. 13, 455\u2013481 (2002).","journal-title":"Cytokine Growth Factor Rev."},{"key":"20444_CR87","doi-asserted-by":"publisher","first-page":"5334","DOI":"10.1038\/s41598-017-05654-w","volume":"7","author":"E Kindstedt","year":"2017","unstructured":"Kindstedt, E. et al. CCL11, a novel mediator of inflammatory bone resorption. Sci. Rep. 7, 5334 (2017).","journal-title":"Sci. Rep."},{"key":"20444_CR88","doi-asserted-by":"publisher","first-page":"5692","DOI":"10.1038\/s41598-020-62562-2","volume":"10","author":"JM Scheffler","year":"2020","unstructured":"Scheffler, J. M. et al. Interleukin 17A: A Janus-faced regulator of osteoporosis. Sci. Rep. 10, 5692 (2020).","journal-title":"Sci. Rep."}],"updated-by":[{"DOI":"10.1038\/s41598-023-31836-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20444-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20444-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20444-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T17:17:02Z","timestamp":1679505422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-20444-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,27]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["20444"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-20444-9","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-023-31836-w","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,27]]},"assertion":[{"value":"22 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-023-31836-w","URL":"https:\/\/doi.org\/10.1038\/s41598-023-31836-w","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RP reports grants from ContraFect, TenNor Therapeutics Limited, and BioFire. RP is a consultant to Next Gen Diagnostics, PathoQuest, PhAST, Torus Biosystems, Day Zero Diagnostics, Mammoth Biosciences, CARB-X, HealthTrackRx and Netflix. Mayo Clinic and RP have a relationship with Adaptive Phage Therapeutics. In addition, RP has a patent on Bordetella pertussis\/parapertussis PCR issued, a patent on a device\/method for sonication with royalties paid by Samsung to Mayo Clinic, and a patent on an anti-biofilm substance issued. RP receives honoraria from the NBME, Up-to-Date and the Infectious Diseases Board Review Course. MPA receives royalties from Stryker on certain hip and knee products and serve on the AAOS Board of Directors. All other authors report no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16135"}}